Comprehensive, easy-to-understand information about this condition
How we create this content →Documentation on capillary malformation-arteriovenous malformation 1 is limited largely due to the rarity of the condition, which affects a small number of individuals worldwide. This rarity restricts the scope of systematic clinical studies and comprehensive data collection. Additionally, the genetic basis was only recently identified, and ongoing clinical characterization is necessary to fully understand the condition and its implications.
The key clinical features of CMAVM1 include capillary malformations, which may appear as red or purple marks on the skin, and arteriovenous malformations, which can lead to complications such as bleeding or pain. While the capillary malformations are highly prevalent among affected individuals, the arteriovenous malformations are less common but can significantly impact health. The variability in symptoms can make diagnosis and management challenging.
To navigate your healthcare journey with CMAVM1, consider seeking a specialist in vascular anomalies or a geneticist with expertise in hereditary vascular conditions. Genetic counseling can provide valuable insights into family planning and risk assessment. While there are currently no identified patient organizations for CMAVM1, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Participating in natural history studies may also be beneficial as they contribute to the understanding of the condition.
Actionable guidance for navigating care for capillary malformation-arteriovenous malformation 1
To navigate your healthcare journey with CMAVM1, consider seeking a specialist in vascular anomalies or a geneticist with expertise in hereditary vascular conditions. Genetic counseling can provide valuable insights into family planning and risk assessment. While there are currently no identified patient organizations for CMAVM1, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Participating in natural history studies may also be beneficial as they contribute to the understanding of the condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation on capillary malformation-arteriovenous malformation 1 is limited largely due to the rarity of the condition, which affects a small number of individuals worldwide. This rarity restricts the scope of systematic clinical studies and comprehensive data collection. Additionally, the genetic basis was only recently identified, and ongoing clinical characterization is necessary to fully understand the condition and its implications.
The key clinical features of CMAVM1 include capillary malformations, which may appear as red or purple marks on the skin, and arteriovenous malformations, which can lead to complications such as bleeding or pain. While the capillary malformations are highly prevalent among affected individuals, the arteriovenous malformations are less common but can significantly impact health. The variability in symptoms can make diagnosis and management challenging.
To navigate your healthcare journey with CMAVM1, consider seeking a specialist in vascular anomalies or a geneticist with expertise in hereditary vascular conditions. Genetic counseling can provide valuable insights into family planning and risk assessment. While there are currently no identified patient organizations for CMAVM1, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Participating in natural history studies may also be beneficial as they contribute to the understanding of the condition.
Actionable guidance for navigating care for capillary malformation-arteriovenous malformation 1
To navigate your healthcare journey with CMAVM1, consider seeking a specialist in vascular anomalies or a geneticist with expertise in hereditary vascular conditions. Genetic counseling can provide valuable insights into family planning and risk assessment. While there are currently no identified patient organizations for CMAVM1, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Participating in natural history studies may also be beneficial as they contribute to the understanding of the condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation on capillary malformation-arteriovenous malformation 1 is limited largely due to the rarity of the condition, which affects a small number of individuals worldwide. This rarity restricts the scope of systematic clinical studies and comprehensive data collection. Additionally, the genetic basis was only recently identified, and ongoing clinical characterization is necessary to fully understand the condition and its implications.
The key clinical features of CMAVM1 include capillary malformations, which may appear as red or purple marks on the skin, and arteriovenous malformations, which can lead to complications such as bleeding or pain. While the capillary malformations are highly prevalent among affected individuals, the arteriovenous malformations are less common but can significantly impact health. The variability in symptoms can make diagnosis and management challenging.
To navigate your healthcare journey with CMAVM1, consider seeking a specialist in vascular anomalies or a geneticist with expertise in hereditary vascular conditions. Genetic counseling can provide valuable insights into family planning and risk assessment. While there are currently no identified patient organizations for CMAVM1, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Participating in natural history studies may also be beneficial as they contribute to the understanding of the condition.
Actionable guidance for navigating care for capillary malformation-arteriovenous malformation 1
To navigate your healthcare journey with CMAVM1, consider seeking a specialist in vascular anomalies or a geneticist with expertise in hereditary vascular conditions. Genetic counseling can provide valuable insights into family planning and risk assessment. While there are currently no identified patient organizations for CMAVM1, resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Participating in natural history studies may also be beneficial as they contribute to the understanding of the condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 2 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning capillary malformation-arteriovenous malformation 1
Updated Dec 19, 2025
A study highlights the use of minimally invasive robotic surgery for treating left lower lobe arteriovenous malformation, showcasing advancements in surgical techniques. This approach may improve patient outcomes and reduce recovery times.